PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
|Articles|August 2, 2019
- Pharmaceutical Technology-08-02-2019
- Volume 43
- Issue 8
Advanced Discharge Systems
Advanced Discharge Systems by Ross are built with mechanisms to fit almost any high-viscosity application and increase efficiency following the mixing process.
Advanced Discharge Systems by Ross are built with mechanisms to fit almost any high-viscosity application and increase efficiency following the mixing process. The machines are equipped with a machined platen fitted with an O-ring that rides against the vessel wall as the platen is lowered hydraulically and pushes down on the product. Scales for dispensing precise dosages and PLC (PID) controls for weighing and dosing are also included.
The DS-10 model (pictured) features a scale system with 10 kg capacity and +/- 3 grams accuracy; a control box that allows data acquisition covering an array of parameters including batch weights, date/time, and speeds; and an IP69K harsh environment-rated scale that protects against dust, high temperature, and high pressure water. A plexiglass enclosure and proximity switches prevent operation of the platen if the mix vessel is not in place and/or the safety shield doors are not closed.
Articles in this issue
about 7 years ago
Quality Risk Management Plans Create Effective Quality Systemsabout 7 years ago
FDA Maps Strategies to Advance Cell and Gene Therapiesabout 7 years ago
Compact Robotic Systems Integrate with Packaging Systemsabout 7 years ago
Floor Mounted Walk-In Hoods for Large Processesabout 7 years ago
The Moon, the Stars, and the Science Lababout 7 years ago
Hygienic Hardwareabout 7 years ago
Combo Drugs Require a Complex Design Approachabout 7 years ago
Balancing CMC Prioritiesabout 7 years ago
Blending Trace Ingredientsabout 7 years ago
Best Practices in the QC Micro LaboratoryRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.